Back
Compare AU
Compare IAF vs. CNEW
Compare shares and ETFs on the ASX that you can trade on Pearler.
Overview
When it comes to investing in the Australian stock market, Exchange-Traded Funds (ETFs) are a popular choice. Two well-known options in the Australian Securities Exchange (ASX) are the iShares Core Composite Bond ETF (IAF) and the VanEck China New Economy ETF (CNEW). In this comparison, we'll delve into these ETFs across various dimensions to help you make an informed investment decision.
Community Stats
IAF | CNEW | |
|---|---|---|
Popularity | Low | Low |
Pearlers invested | 518 | 66 |
Median incremental investment | $1,066.65 | $824.12 |
Median investment frequency | Monthly | Monthly |
Median total investment | $3,035.10 | $1,842.65 |
Average age group | > 35 | > 35 |
Key Summary
IAF | CNEW | |
|---|---|---|
Strategy | IAF.AX was created on 2012-03-12 by iShares. The fund's investment portfolio concentrates primarily on investment grade fixed income. The ETF currently has 3247.06m in AUM and 594 holdings. The fund aims to provide investors with the performance of the Bloomberg AusBond Composite 0+ Yr IndexSM, before fees and expenses. The index is designed to measure the performance of the Australian bond market and includes investment grade fixed income securities issued by the Australian Treasury. | CNEW.AX was created on 2018-11-08 by VanEck. The fund's investment portfolio concentrates primarily on total market equity. CNEW.AX gives investors a portfolio of the most fundamentally sound companies in China having the best growth prospects in sectors making up the New Economy, namely technology, health care, consumer staples and consumer discretionary. CNEW.AX aims to provide investment returns, before fees and other costs, which track the performance of the Index. |
Top 3 holdings | AUSTRALIA (COMMONWEALTH OF) RegS (2.49 %) AUSTRALIA (COMMONWEALTH OF) RegS (2.44 %) AUSTRALIA (COMMONWEALTH OF) RegS (2.40 %) | Suzhou Zelgen Biopharmaceuticals Co Ltd Class A (1.33 %) Shanghai Allist Pharmaceuticals Co Ltd Class A (1.31 %) Haisco Pharmaceutical Group Co Ltd Class A (1.30 %) |
Top 3 industries | Other (99.31 %) Financials (0.25 %) Communication Services (0.19 %) | Information Technology (33.78 %) Health Care (27.01 %) Consumer Discretionary (20.43 %) |
Top 3 countries | China (100.00 %) | |
Management fee | 0.15 % | 0.95 % |
Key Summary
IAF | CNEW | |
|---|---|---|
Issuer | iShares | VanEck |
Tracking index | Bloomberg AusBond Composite 0+ Yr Index - AUD | CSI MarketGrader China New Economy Index - CNY |
Asset class | ETF | ETF |
Management fee | 0.15 % | 0.95 % |
Price | $101.00 | $7.62 |
Size | $3.709 billion | $102.854 million |
10Y return | -7.26 % | N/A |
Annual distribution yield (5Y) | 2.22 % | 1.33 % |
Market | ASX | ASX |
First listed date | 14/03/2012 | 09/11/2018 |
Purchase fee | $6.50 | $6.50 |
Community Stats
IAF | CNEW | |
|---|---|---|
Popularity | Low | Low |
Pearlers invested | 518 | 66 |
Median incremental investment | $1,066.65 | $824.12 |
Median investment frequency | Monthly | Monthly |
Median total investment | $3,035.10 | $1,842.65 |
Average age group | > 35 | > 35 |
Pros and Cons
IAF | CNEW | |
|---|---|---|
Pros |
| |
Cons |
|
IAF | CNEW |
|---|---|
Lower management fee | Higher management fee |
Higher price growth | Lower price growth |
Higher distribution yield | Lower distribution yield |